Search

Author/Creator Toleikis, Lars

1. 195 Avelumab internalization and lysosomal degradation by circulating immune cells in human is mediated by both Fc gamma Receptor (FcgR) and PD-L1 binding. (9th November 2020)

Authors:
Jin, Hulin; D'Urso, Vittorio; Neuteboom, Berend; McKenna, Sean; Schweickhardt, Rene; Gross, Alec; Nanfack, Yves Fomekong; Toleikis, Lars; Fluck, Markus; Scheuenpflug, Juergen; Cai, Ti
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A115
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Avelumab internalization by human circulating immune cells is mediated by both Fc gamma receptor and PD-L1 binding. (1st January 2021)

Authors:
Jin, Hulin; D'Urso, Vittorio; Neuteboom, Berend; McKenna, Sean D.; Schweickhardt, Rene; Gross, Alec W.; Fomekong Nanfack, Yves; Paoletti, Andrea; Carter, Carina; Toleikis, Lars; Fluck, Markus; Scheuenpflug, Juergen; Cai, Ti
Journal:
Oncoimmunology
Issue:
Volume 10:Number 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Beyond bispecificity: Controlled Fab arm exchange for the generation of antibodies with multiple specificities. Issue 1 (31st December 2022)

Authors:
Yanakieva, Desislava; Pekar, Lukas; Evers, Andreas; Fleischer, Markus; Keller, Stephan; Mueller-Pompalla, Dirk; Toleikis, Lars; Kolmar, Harald; Zielonka, Stefan; Krah, Simon
Journal:
MAbs
Issue:
Volume 14:Issue 1(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗